HomeOwner Search
Visit USCO2007
Category SearchPredictability considerations in aminoglycoside therapy a slide-lecture kit Angela M. Ristuccia
![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
Predictability considerations in aminoglycoside therapy a slide-lecture kit Angela M. Ristuccia
Status
Published
on 14 Jun 2007
Year of Creation
1987
Copyright Claimant
Bristol-Myers Company
Registration Number
TX0002656509
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0002656509) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Predictability considerations in aminoglycoside therapy a slide-lecture kit Angela M. Ristuccia" created in 1987. The copyright holder is Bristol-Myers Company, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Bristol-Myers Company.
Application Details
Registration Number
TX0002656509
Registration Date
6/14/2007
Year of Creation
1987
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Bristol-Myers Company
Physical Description
2 v. + 20 col. slides in folder
Corporate Authors
Statements
Author Statement: Bristol-Myers Company, employer for hire
© 2023 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.